FDA Watch: CDRH Budget May Not See Steep Cuts in FY 2026
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
From – Diagnostic Testing & Emerging Technologies
Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for…
From – Laboratory Industry Report
Although volume of diagnostics industry mergers and acquisitions was up slightly in 2016, the big story of the year were the deals that…
From – Laboratory Industry Report
Abbott officially wants out of its $5.8 billion merger with Alere. Last week, the Illinois-based diagnostics giant asked a Delaware Chancery Court to…
From – Laboratory Industry Report
Provista Diagnostics, a New York City-based molecular laboratory has concluded that the age of patients can play a role in the…